☆ 4.8 Article

Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Hematology

Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura

Azra Borogovac et al.

Summary: Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare disorder that often results in severe health issues and premature death. Current prophylaxis methods are not sufficient, highlighting the need for increased awareness and earlier implementation of more effective prevention treatments.

BLOOD ADVANCES (2022)

Add to Collection

Review Medicine, General & Internal

Preeclampsia

Laura A. Magee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Hematology

Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura

Erika Tarasco et al.

Summary: This study provides prospective data on 87 patients with hereditary thrombotic thrombocytopenic purpura, revealing a lower annual incidence of acute episodes in this population but a higher risk of episodes in pediatric patients, with prophylactic plasma infusion regimens being inadequate in preventing acute episodes.

BLOOD (2021)

Add to Collection

Article Hematology

Redefining outcomes in immune TTP: an international working group consensus report

Adam Cuker et al.

Summary: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a potentially fatal disease caused by severe deficiency of ADAMTS13, and standardized definitions of response and exacerbation primarily based on platelet count have been modified to incorporate ADAMTS13 activity and the effects of anti-VWF therapy. The revised definitions distinguish between clinical and ADAMTS13 remission and relapse, and are benchmarked against not only the timing of discontinuation of therapeutic plasma exchange (TPE) but also that of anti-VWF therapy. Validation of the revised definitions is retrospective, with discussion on the clinical implications of the updated outcome definitions.

BLOOD (2021)

Add to Collection

Review Hematology

Seronegative antiphospholipid syndrome: refining the value of non-criteria antibodies for diagnosis and clinical management

Pasquale Pignatelli et al.

HAEMATOLOGICA (2020)

Add to Collection

Article Hematology

Thrombotic thrombocytopenic purpura masquerading as preclampsia with severe features at 13 weeks' gestation

Eric J. Avery et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Add to Collection

Article Hematology

ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura

X. Long Zheng et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

X. Long Zheng et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Ferras Alwan et al.

BLOOD (2019)

Add to Collection

Article Hematology

The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017

Hendrika A. van Dorland et al.

HAEMATOLOGICA (2019)

Add to Collection

Review Medicine, General & Internal

Hereditary Thrombotic Thrombocytopenic Purpura

Johanna A. Kremer Hovinga et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Review Immunology

Maternal vascular malperfusion of the placental bed

Linda M. Ernst

APMIS (2018)

Add to Collection

Article Medicine, General & Internal

Thrombotic thrombocytopenic purpura

Johanna A. Kremer Hovinga et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Add to Collection

Article Hematology

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

Marie Scully et al.

BLOOD (2017)

Add to Collection

Article Hematology

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Evaren E. Page et al.

BLOOD ADVANCES (2017)

Add to Collection

Article Hematology

High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence

A. S. von Krogh et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

Add to Collection

Article Hematology

Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes

Marie Scully et al.

BLOOD (2014)

Add to Collection

Article Hematology

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura

Marie Moatti-Cohen et al.

BLOOD (2012)

Add to Collection

Article Hematology

Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura

Rahel Froehlich-Zahnd et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)

Add to Collection

Review Hematology

Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan

Y. Fujimura et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)

Add to Collection

Article Hematology

Survival and relapse in patients with thrombotic thrombocytopenic purpura

Johanna A. Kremer Hovinga et al.

BLOOD (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.